StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics cash

Cash and short-term investments held at the end of each period.

Northwest Biotherapeutics's cash was $595.00K at Jun 30, 2026. For fiscal 2025 it was $3.04M, up 39.8% from the year before. Over ten years it grew -18.3% a year on average. The highest annual figure on record is $23.05M in fiscal 2015.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.04M+39.8%
FY2024Dec 31, 2024$2.18M+2.3%
FY2023Dec 31, 2023$2.13M-69.5%
FY2022Dec 31, 2022$6.97M-54.1%
FY2021Dec 31, 2021$15.17M+51.9%
FY2020Dec 31, 2020$9.98M+2583.6%
FY2019Dec 31, 2019$372.00K-98.3%
FY2018Dec 31, 2018$22.22M+18894.9%
FY2017Dec 31, 2017$117.00K-98.3%
FY2016Dec 31, 2016$6.87M-70.2%
FY2015Dec 31, 2015$23.05M+43.9%
FY2014Dec 31, 2014$16.02M-13.4%
FY2013Dec 31, 2013$18.50M+151.8%
FY2012Dec 31, 2012$7.35M+30508.3%
FY2011Dec 31, 2011$24.00K-84.3%
FY2010Dec 31, 2010$153.00K+135.4%
FY2009Dec 31, 2009$65.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$595.00K-86.2%
Q1 FY2026Mar 31, 2026$1.79M-35.7%
Q4 FY2025Dec 31, 2025$3.04M+39.8%
Q3 FY2025Sep 30, 2025$4.56M+55.2%
Q2 FY2025Jun 30, 2025$4.32M+49.8%
Q1 FY2025Mar 31, 2025$2.78M+12.1%
Q4 FY2024Dec 31, 2024$2.18M+2.3%
Q3 FY2024Sep 30, 2024$2.94M-51.8%
Q2 FY2024Jun 30, 2024$2.88M+102.3%
Q1 FY2024Mar 31, 2024$2.48M-60.0%
Q4 FY2023Dec 31, 2023$2.13M-69.5%
Q3 FY2023Sep 30, 2023$6.10M-35.3%
Q2 FY2023Jun 30, 2023$1.42M-70.5%
Q1 FY2023Mar 31, 2023$6.19M-11.1%
Q4 FY2022Dec 31, 2022$6.97M-54.1%
Q3 FY2022Sep 30, 2022$9.43M+145.7%
Q2 FY2022Jun 30, 2022$4.83M+28.6%
Q1 FY2022Mar 31, 2022$6.96M-30.3%
Q4 FY2021Dec 31, 2021$15.17M+64.0%
Q3 FY2021Sep 30, 2021$3.84M-35.6%
Q2 FY2021Jun 30, 2021$3.76M+391.9%
Q4 FY2020Dec 31, 2020$9.98M+2583.6%
Q3 FY2020Sep 30, 2020$9.25M+369.5%
Q2 FY2020Jun 30, 2020$5.96M-10.8%
Q1 FY2020Mar 31, 2020$764.00K-61.2%
Q4 FY2019Dec 31, 2019$372.00K-98.3%
Q3 FY2019Sep 30, 2019$1.97M+694.4%
Q2 FY2019Jun 30, 2019$6.68M+318.0%
Q1 FY2019Mar 31, 2019$1.97M+894.9%
Q4 FY2018Dec 31, 2018$22.22M+18894.9%
Q3 FY2018Sep 30, 2018$248.00K-76.4%
Q2 FY2018Jun 30, 2018$1.60M-76.8%
Q1 FY2018Mar 31, 2018$198.00K-86.7%
Q4 FY2017Dec 31, 2017$117.00K-96.2%
Q3 FY2017Sep 30, 2017$1.05M-91.7%
Q4 FY2016Dec 31, 2016$6.87M-70.2%
Q3 FY2016Sep 30, 2016$1.49M–
Q2 FY2016Jun 30, 2016$3.10M–
Q1 FY2016Mar 31, 2016$12.65M–
Q4 FY2015Dec 31, 2015$23.05M–

More Northwest Biotherapeutics figures

See a number that looks wrong?